Evidence map›Paper›PMID 27651922›Full record

ArticleRMD open2016

Association between RANK, RANKL and OPG polymorphisms with ACPA and erosions in rheumatoid arthritis: results from a meta-analysis involving three French cohorts.

Adeline Ruyssen-Witrand, Yannick Degboé, A Cantagrel, D Nigon, C Lukas, S Scaramuzzino, Y Allanore, O Vittecoq, T Schaeverbeke, J Morel and 4 more

Open access · goldAbstract read
In one paragraph

Article in RMD open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Adeline Ruyssen-WitrandUMR 1027, INSERM, Toulouse, France; University Paul Sabatier Toulouse III, Toulouse, France; Rheumatology Center, Purpan Hospital, Toulouse, France.
Yannick DegboéUniversity Paul Sabatier Toulouse III, Toulouse, France; Rheumatology Center, Purpan Hospital, Toulouse, France; UMR 1043, INSERM, Toulouse, France.
A CantagrelUniversity Paul Sabatier Toulouse III, Toulouse, France; Rheumatology Center, Purpan Hospital, Toulouse, France; UMR 1043, INSERM, Toulouse, France.
D NigonRheumatology Center, Purpan Hospital , Toulouse , France.
C LukasRheumatology Department , Lapeyronie Teaching Hospital , Montpellier , France.
S ScaramuzzinoUMR 1027, INSERM, Toulouse, France; University Paul Sabatier Toulouse III, Toulouse, France.
Y AllanoreRheumatology Department , Cochin Teaching Hospital , Paris , France.
O VittecoqDepartment of Rheumatology , Rouen University Hospital & INSERM U905 , Rouen , France.
T SchaeverbekeRheumatology Department , Pellegrin Hospital , Bordeaux , France.
J MorelRheumatology Department , Lapeyronie Teaching Hospital , Montpellier , France.
J SibiliaDepartment of Rheumatology , Hôpitaux Universitaires de Strasbourg, Université de Strasbourg , Strasbourg , France.
A Cambon-ThomsenUMR 1027, INSERM, Toulouse, France; University Paul Sabatier Toulouse III, Toulouse, France.
P DieudéRheumatology Department , Claude Bernard-Bichat Teaching Hospital, Paris VII University , Paris , France.
A ConstantinUniversity Paul Sabatier Toulouse III, Toulouse, France; Rheumatology Center, Purpan Hospital, Toulouse, France; UMR 1043, INSERM, Toulouse, France.
Inserm · FRUniversité Toulouse III - Paul Sabatier · FRHôpital Lapeyronie · FRHôpital Cochin · FRHôpital Pellegrin · FRHôpital Purpan · FRHôpitaux Universitaires de Strasbourg · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe RANK/RANKL/osteoprotegerin (OPG) system plays a central role in the pathogenesis of bone erosions in rheumatoid arthritis (RA). The aim of this study was to test the association between 11 single-nucleotide polymorphisms (SNPs) located on RANK, RANKL and OPG genes and anticitrullinated peptide antibody (ACPA) presence or erosions in RA.

methodsPATIENTS: This work was performed on three independent samples of French patients with RA: the Etude de Suivi des PolyArthrites Indifférenciées Récentes (ESPOIR) (n=632), Rangueil Midi-Pyrénées (RMP) (n=249) and French Rheumatoid Arthritis Genetic Consortium (FRAGC) (n=590) cohorts. Genotyping: the genotyping of 11 SNPs located on RANK, RANKL and OPG were performed by PCR. STATISTICAL ANALYSES: The association between the genotypes with ACPA or erosions was first tested in the ESPOIR cohort using a χ(2) test and, in the case of significant association, replicated in the RMP and FRACG cohorts. A meta-analysis on the three cohorts was performed using the Mantel-Haenszel method.

resultsOne SNP on RANK (rs8086340) and three SNPs on RANKL (rs7984870, rs7325635, rs1054016) were significantly associated with ACPA presence, while one SNP on OPG (rs2073618) and one SNP on RANKL (rs7325635) were significantly associated with erosions in the ESPOIR cohort. Following meta-analysis performed on the three samples, the SNP on RANK and the GGG haplotype of the three SNPs located on RANKL were both significantly associated with ACPA presence, while only the SNP on OPG remained significantly associated with erosions.

conclusionsThis study identified one SNP located on RANK, one haplotype on RANKL associated with ACPA presence, and one SNP located on OPG associated with erosions in three different samples of French patients with RA.

Indexed as

Ant-CCPGene PolymorphismRheumatoid Arthritis

Identifiers

PMID27651922
PMCPMC5020667
OpenAlexW2509375210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.